SCHEMBL1475481

SCHEMBL1475481

COc1ccc(COCc2ccc(OC)cc2)cc1.[Na]

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.64
AGXT P21549 2/20 0.64
CA1 P00915 2/20 0.56
CA2 P00918 2/20 0.56
APP P05067 7/20 0.55
CA12 O43570 1/20 0.55
CA7 P43166 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
MAOB P27338 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
LTA4H P09960 1/20 0.52
TAAR1 Q96RJ0 1/20 0.52
CALM1 P0DP23 1/20 0.52
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34413 0.97 IDO1 (0.67) IDO1AGXTCA1CA2APP
Methoxymethane SCHEMBL28823290 0.95 IDO1 (0.64) IDO1AGXTCA1CA2APP
Hydrochloric Acid SCHEMBL28912134 0.95 IDO1 (0.68) IDO1AGXTCA1CA2APP
Bromide SCHEMBL28558295 0.95 IDO1 (0.64) IDO1AGXTCA1CA2APP
Potassium SCHEMBL1477050 0.95 IDO1 (0.64) IDO1AGXTCA1CA2APP
Methyl Alcohol SCHEMBL28823289 0.93 IDO1 (0.61) IDO1AGXTCA1CA2APP
SCHEMBL11132718 0.91 IDO1 (0.59) IDO1AGXTCA1CA2APP
SCHEMBL11132720 0.91 LTA4H (0.65) IDO1AGXTCA1CA2APP
SCHEMBL9292118 0.89 ACHE (0.65) IDO1AGXTCA1CA2APP
SCHEMBL6429953 0.89 LTA4H (0.69) IDO1AGXTCA1CA2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915274-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-03-29 US disclosed
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same OZAKI FUMIHIRO 2007-12-20 US disclosed
US-7265108-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI CO., LTD. (JP) 2007-09-04 US disclosed
EP-1484327-B1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF EISAI R&D MAN CO LTD (JP) 2007-08-01 EP disclosed
US-6995144-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI CO., LTD. (JP) 2006-02-07 US disclosed
US-20050245527-A1 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-03 US disclosed
EP-1484327-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF Eisai Co., Ltd. (JP) 2004-12-08 EP disclosed
US-20040167224-A1 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same XDH, NQO1, CYP1A1 IDO1 863/4885AGXT 1704/4885CA1 725/4885
US-20040167224-A1 Nitrogen containing heterocyclic compounds and medicines containing the same NQO1, CBR1, NOX1 IDO1 959/4885AGXT 2446/4885CA1 862/4885
US-20050245527-A1 Nitrogen containing heterocyclic compounds and medicines containing the same XDH, NQO1, CYP1A1 IDO1 863/4885AGXT 1704/4885CA1 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.